These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14733735)

  • 1. Innate immunity to herpes simplex virus type 2.
    Duerst RJ; Morrison LA
    Viral Immunol; 2003; 16(4):475-90. PubMed ID: 14733735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo.
    Murphy JA; Duerst RJ; Smith TJ; Morrison LA
    J Virol; 2003 Sep; 77(17):9337-45. PubMed ID: 12915549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
    Lee AJ; Ashkar AA
    Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mucosal immunity in preventing genital herpes infection.
    MasCasullo V; Fam E; Keller MJ; Herold BC
    Viral Immunol; 2005; 18(4):595-606. PubMed ID: 16359226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of herpes simplex virus type 2 (HSV-2) -specific cell-mediated immune responses in guinea pigs during latent HSV-2 genital infection.
    Perry CL; Banasik BN; Gorder SR; Xia J; Auclair S; Bourne N; Milligan GN
    J Immunol Methods; 2016 Dec; 439():1-7. PubMed ID: 27659010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection.
    Gill N; Davies EJ; Ashkar AA
    Am J Reprod Immunol; 2008 Jan; 59(1):35-43. PubMed ID: 18154594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model.
    Kwant-Mitchell A; Ashkar AA; Rosenthal KL
    J Virol; 2009 Oct; 83(20):10664-76. PubMed ID: 19656896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challenges.
    Harandi AM
    J Clin Virol; 2004 Jul; 30(3):207-10. PubMed ID: 15135735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-Resident-Memory CD8
    Peng T; Phasouk K; Sodroski CN; Sun S; Hwangbo Y; Layton ED; Jin L; Klock A; Diem K; Magaret AS; Jing L; Laing K; Li A; Huang ML; Mertens M; Johnston C; Jerome KR; Koelle DM; Wald A; Knipe DM; Corey L; Zhu J
    Front Immunol; 2021; 12():735643. PubMed ID: 34552595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
    Tengvall S; Harandi AM
    J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S; O'Hagan D; Harandi AM
    Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurokinin 1 receptor signaling affects the local innate immune defense against genital herpes virus infection.
    Svensson A; Kaim J; Mallard C; Olsson A; Brodin E; Hökfelt T; Eriksson K
    J Immunol; 2005 Nov; 175(10):6802-11. PubMed ID: 16272337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate and adaptive immunity against herpes simplex virus type 2 in the genital mucosa.
    Chan T; Barra NG; Lee AJ; Ashkar AA
    J Reprod Immunol; 2011 Mar; 88(2):210-8. PubMed ID: 21334750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of herpes simplex virus immunity and pathogenesis.
    Kollias CM; Huneke RB; Wigdahl B; Jennings SR
    J Neurovirol; 2015 Feb; 21(1):8-23. PubMed ID: 25388226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OASL1 deficiency promotes antiviral protection against genital herpes simplex virus type 2 infection by enhancing type I interferon production.
    Oh JE; Lee MS; Kim YJ; Lee HK
    Sci Rep; 2016 Jan; 6():19089. PubMed ID: 26750802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity.
    Harandi AM; Svennerholm B; Holmgren J; Eriksson K
    J Virol; 2001 Jul; 75(14):6705-9. PubMed ID: 11413339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
    Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
    Gill N; Rosenthal KL; Ashkar AA
    J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.